Home > Healthcare > U.S. Hormone Replacement Therapy Market > Table of Contents

U.S. Hormone Replacement Therapy Market - By Product (Estrogen, Progesterone, Thyroid, Growth Hormone, Testosterone), Route of Administration (Oral, Parenteral), Disease (Menopause, Growth Hormone Deficiency), Distribution Channel, Forecast 2023-2032

  • Report ID: GMI7407
  • Published Date: Nov 2023
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market definition

1.2    Base estimates & calculations

1.3    Forecast calculation

1.4    Covid-19 impact analysis at global level

1.5    Data validation

1.6    Data sources

1.6.1    Primary

1.6.2    Secondary

1.6.2.1   Paid sources

1.6.2.2   Public sources

Chapter 2   Executive Summary

2.1    U.S. hormone replacement therapy industry 360º synopsis, 2018 – 2032 (USD Million)

2.1.1    Business trends

Chapter 3   U.S. Hormone Replacement Therapy Market Insights

3.1    Industry landscape, 2018 – 2032 (USD Million)

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1   Increasing geriatric population

3.2.1.2   Rising awareness of post-menopausal issues

3.2.1.3   Increasing development of novel drug delivery systems for hormone imbalance issues

3.2.1.4   Rising prevalence of hormonal disorders

3.2.2    Industry pitfalls & challenges

3.2.2.1   High cost associated with hormone replacement therapy

3.2.2.2   Adverse effects of hormone replacement therapy

3.3    Growth potential analysis

3.3.1    By product

3.3.2    By route of administration

3.3.3    By disease type

3.3.4    By distribution channel

3.4    COVID-19 impact analysis

3.5    Regulatory landscape

3.6    Porter’s analysis

3.7    PESTEL analysis

Chapter 4   Competitive Landscape, 2022

4.1    Introduction

4.2    Company matrix analysis, 2022

4.3    Competitive analysis of major market players, 2022

4.4    Competitive positioning matrix, 2022

4.5    Strategic dashboard, 2022

Chapter 5   U.S. Hormone Replacement Therapy Market Estimates and Forecast, By Product, 2018 - 2032 (USD Million)

5.1    Key trends, by product

5.2    Estrogen & progesterone replacement therapy

5.3    Thyroid replacement therapy

5.4    Growth hormone replacement therapy

5.5    Parathyroid hormone replacement therapy

5.6    Testosterone replacement therapy

Chapter 6   U.S. Hormone Replacement Therapy Market Estimates and Forecast, By Route of Administration, 2018 - 2032 (USD Million)

6.1    Key trends, by route of administration

6.2    Oral

6.3    Parenteral

6.4    Other routes of administration

Chapter 7   U.S. Hormone Replacement Therapy Market Estimates and Forecast, By Disease Type, 2018 - 2032 (USD Million)

7.1    Key trends, by disease type

7.2    Menopause

7.3    Growth hormone deficiency

7.4    Male hypogonadism

7.5    Hypothyroidism

7.6    Hypoparathyroidism

7.7    Other disease types

Chapter 8   U.S. Hormone Replacement Therapy Market Estimates and Forecast, By Distribution Channel, 2018 - 2032 (USD Million)

8.1    Key trends, by distribution channel

8.2    Hospital pharmacies

8.3    Retail pharmacies

8.4    Online pharmacies

Chapter 9   Company Profiles

9.1    Eli Lilly and Company

9.2    Bayer AG

9.3    Pfizer Inc.

9.4    Viatris, Inc.

9.5    Noven Pharmaceuticals, Inc.

9.6    Merck KGaA

9.7    Novo Nordisk A/S

9.8    F. Hoffmann-La Roche Ltd.

9.9    ASCEND Therapeutics US, LLC.

9.10    Abbott Laboratories

9.11    Teva Pharmaceutical Industries Ltd.

9.12    Novartis AG
 

Data Tables

TABLE 1    Market revenue, by product (2022)

TABLE 2    Market revenue, by route of administration (2022)

TABLE 3    Market revenue, by disease type (2022)

TABLE 4    Market revenue, by distribution channel (2022)

TABLE 5    U.S. hormone replacement therapy market size, 2018 – 2022 (USD Million)

TABLE 6    U.S. hormone replacement therapy market size, 2023 – 2032 (USD Million)

TABLE 7    Industry impact forces

TABLE 8    Competitive positioning matrix: Classification criteria

TABLE 9    Estrogen & progesterone replacement therapy market size, 2018 - 2022 (USD Million)

TABLE 10   Estrogen & progesterone replacement therapy market size, 2023 - 2032 (USD Million)

TABLE 11   Thyroid replacement therapy market size, 2018 - 2022 (USD Million)

TABLE 12   Thyroid replacement therapy market size, 2023 - 2032 (USD Million)

TABLE 13   Growth hormone replacement therapy market size, 2018 - 2022 (USD Million)

TABLE 14   Growth hormone replacement therapy market size, 2023 - 2032 (USD Million)

TABLE 15   Parathyroid hormone replacement therapy market size, 2018 - 2022 (USD Million)

TABLE 16   Parathyroid hormone replacement therapy market size, 2023 - 2032 (USD Million)

TABLE 17   Testosterone replacement therapy market size, 2018 - 2022 (USD Million)

TABLE 18   Testosterone replacement therapy market size, 2023 - 2032 (USD Million)

TABLE 19   Oral market size, 2018 - 2022 (USD Million)

TABLE 20   Oral market size, 2023 - 2032 (USD Million)

TABLE 21   Parenteral market size, 2018 - 2022 (USD Million)

TABLE 22   Parenteral market size, 2023 - 2032 (USD Million)

TABLE 23   s market size, 2018 - 2022 (USD Million)

TABLE 24   Other routes of administration market size, 2023 - 2032 (USD Million)

TABLE 25   Menopause market size, 2018 - 2022 (USD Million)

TABLE 26   Menopause market size, 2023 - 2032 (USD Million)

TABLE 27   Growth hormone deficiency market size, 2018 - 2022 (USD Million)

TABLE 28   Growth hormone deficiency market size, 2023 - 2032 (USD Million)

TABLE 29   Male hypogonadism market size, 2018 - 2022 (USD Million)

TABLE 30   Male hypogonadism market size, 2023 - 2032 (USD Million)

TABLE 31   Hypothyroidism market size, 2018 - 2022 (USD Million)

TABLE 32   Hypothyroidism market size, 2023 - 2032 (USD Million)

TABLE 33   Hypoparathyroidism market size, 2018 - 2022 (USD Million)

TABLE 34   Hypoparathyroidism market size, 2023 - 2032 (USD Million)

TABLE 35   Other disease types market size, 2018 - 2022 (USD Million)

TABLE 36   Other disease types market size, 2023 - 2032 (USD Million)

TABLE 37   Hospital pharmacies market size, 2018 - 2022 (USD Million)

TABLE 38   Hospital pharmacies market size, 2023 - 2032 (USD Million)

TABLE 39   Retail pharmacies market size, 2018 - 2022 (USD Million)

TABLE 40   Retail pharmacies market size, 2023 - 2032 (USD Million)

TABLE 41   Online pharmacies market size, 2018 - 2022 (USD Million)

TABLE 42   Online pharmacies market size, 2023 - 2032 (USD Million)
 

Charts & Figures

FIG 1   GMI report coverage: Critical research elements

FIG 2   Top-down approach

FIG 3   Market estimation and forecast methodology

FIG 4   Market forecasting methodology

FIG 5   Breakdown of primary participants

FIG 6   U.S. hormone replacement therapy industry 360º synopsis, 2018 – 2032

FIG 7   Industry landscape, 2018 - 2032 (USD Million)

FIG 8   Growth potential analysis, by product

FIG 9   Growth potential analysis, by route of administration

FIG 10   Growth potential analysis, by disease type

FIG 11   Growth potential analysis, by distribution channel

FIG 12   Porter’s analysis

FIG 13   PESTEL analysis

FIG 14   Company matrix analysis, 2022

FIG 15   Global company market share analysis, 2022

FIG 16   Competitive analysis of major market players, 2022

FIG 17   Competitive positioning matrix, 2022

FIG 18   Strategic dashboard, 2022
 

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 12
  • Tables & Figures: 60
  • Countries covered: 1
  • Pages: 91
 Download Free Sample